If you are diabetic and find you have trouble avoiding sugary beverages, consider the sweeteners allulose, monk fruit and stevia without erythritol, a commonly used artificial sweetener that has been linked to an increased risk of heart attack and stroke.

An FDA-approved medication already used to treat people who have type 2 diabetes and chronic kidney disease may also help lower their stroke and heart attack risk, a new study has found.

A common artificial sweetener may trigger insulin spikes that lead to the build up of fatty plaques in the arteries, increasing the risk of heart attacks and strokes, a new study in mice indicates.

A new study found that a drug recently approved to treat type 2 diabetes and kidney disease in patients with additional cardiovascular risk factors can also reduce the risk of heart attacks and

The common artificial sweetener aspartame could be putting consumers at greater risk of heart disease through a newly discovered chemical trigger on the lining of arteries. Researchers from Sweden, China,

A common artificial sweetener can trigger dangerous insulin spikes, warns a new study. The spikes led to blood vessel inflammation in mice - which raises the risk of a heart attack or stroke, say scientists.